|
|
Advertisement
Webinar: RBM-Enabling Technology: Analytics with Action
In the process of evaluating risk-based monitoring technologies? There are several important elements to consider when determining which solution is right for your organization. In this webinar, RBM technology pioneer Trevor McCaw will explain how to tell if an RBM tool is truly framed around risk and quality principles.
 Register for the webinar > >
|
|
Advertisement
Demystifying genomics for drug developers
Live Webcast: Tuesday, May 19, 2015 at 1:00 p.m. EDT
With the US federal government now backing a Precision Medicine Initiative, genomics, personalized medicines, bioinformatics, and next-generation sequencing have stepped into the spotlight and become new buzzwords for drug developers. But what do all of these terms mean? In this webinar we will explore genomic applications to precision medicine programs and shed light on how genomics is transforming drug development.
 Register for free >>
|
|
Sponsored
DBcaps® capsules are uniquely designed for double-blind clinical trials. They can improve patient compliance, as well as reduce bias, when used in clinical trials to over-encapsulate comparator products.
 Learn more
|
Sponsored
Change Investigation Site Relationships for the better
On Demand
 Click here
to Register Free
|
|
| |
ACT TV
Tune in to ACT TV, our new video channel, features regular interviews with experts on popular topics in clinical trials, and drug development. Programming includes Listening to Social Media, eConsent, Orphan Drugs, Risk-Based Monitoring and more.
Watch More. |
|
|
